SCHEMBL31583269

SCHEMBL31583269

Cn1nc(Cl)c2cccc(Br)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ DDB1 Q16531 2/20 0.32
▸ CRBN Q96SW2 2/20 0.32
▸ ENPP3 O14638 1/20 0.32
▸ ENPP1 P22413 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ BTK Q06187 1/20 0.31
▸ ESR1 P03372 1/20 0.30
▸ PDPK1 O15530 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30706223 0.81 LMNA (0.37) L3MBTL1LMNATP53THRBTLR9
SCHEMBL13106346 0.79 LMNA (0.43) L3MBTL1LMNATP53THRBTLR9
SCHEMBL15995629 0.78 LMNA (0.34) L3MBTL1LMNATP53THRBTLR9
SCHEMBL15995385 0.78 DDB1 (0.38) L3MBTL1LMNATP53THRBTLR9
SCHEMBL15687253 0.76 ESR1 (0.35) L3MBTL1RXFP1LMNATP53ALDH1A1
SCHEMBL31582758 0.76 DDB1 (0.43) L3MBTL1LMNATP53THRBTLR9
SCHEMBL14077453 0.75 L3MBTL1 (0.41) L3MBTL1LMNATP53THRBTLR9
SCHEMBL7572834 0.75 KMT2A (0.37) L3MBTL1RXFP1LMNAHTT
SCHEMBL31582651 0.75 LMNA (0.35) L3MBTL1LMNATP53THRBTLR9
SCHEMBL31582863 0.75 ADORA3 (0.40) L3MBTL1LMNATP53THRBTLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106644-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2025-05-22 — — WO disclosed
Send feedback